211 related articles for article (PubMed ID: 9042989)
1. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy.
Horsmans Y; Solbreux PM; Daenens C; Desager JP; Geubel AP
Aliment Pharmacol Ther; 1997 Feb; 11(1):165-70. PubMed ID: 9042989
[TBL] [Abstract][Full Text] [Related]
2. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
Morgan MY; Alonso M; Stanger LC
J Hepatol; 1989 Mar; 8(2):208-17. PubMed ID: 2654285
[TBL] [Abstract][Full Text] [Related]
3. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
Sharma P; Sharma BC; Sarin SK
Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.
Watanabe A; Sakai T; Sato S; Imai F; Ohto M; Arakawa Y; Toda G; Kobayashi K; Muto Y; Tsujii T; Kawasaki H; Okita K; Tanikawa K; Fujiyama S; Shimada S
Hepatology; 1997 Dec; 26(6):1410-4. PubMed ID: 9397979
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study.
Poo JL; Góngora J; Sánchez-Avila F; Aguilar-Castillo S; García-Ramos G; Fernández-Zertuche M; Rodríguez-Fragoso L; Uribe M
Ann Hepatol; 2006; 5(4):281-8. PubMed ID: 17151582
[TBL] [Abstract][Full Text] [Related]
6. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
Sharma P; Sharma BC; Agrawal A; Sarin SK
J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
[TBL] [Abstract][Full Text] [Related]
7. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
Agrawal A; Sharma BC; Sharma P; Sarin SK
Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
[TBL] [Abstract][Full Text] [Related]
8. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.
Shen YC; Chang YH; Fang CJ; Lin YS
Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342
[TBL] [Abstract][Full Text] [Related]
9. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
[TBL] [Abstract][Full Text] [Related]
10. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.
Wang JY; Bajaj JS; Wang JB; Shang J; Zhou XM; Guo XL; Zhu X; Meng LN; Jiang HX; Mi YQ; Xu JM; Yang JH; Wang BS; Zhang NP
J Dig Dis; 2019 Oct; 20(10):547-556. PubMed ID: 31448533
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.
Dhiman RK; Sawhney MS; Chawla YK; Das G; Ram S; Dilawari JB
Dig Dis Sci; 2000 Aug; 45(8):1549-52. PubMed ID: 11007104
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding.
Aires FT; Ramos PT; Bernardo WM
Rev Assoc Med Bras (1992); 2016; 62(3):243-7. PubMed ID: 27310548
[TBL] [Abstract][Full Text] [Related]
13. Profile of hepatic encephalopathy in children with cirrhosis and response to lactulose.
Sharma P; Sharma BC
Saudi J Gastroenterol; 2011; 17(2):138-41. PubMed ID: 21372353
[TBL] [Abstract][Full Text] [Related]
14. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
Sharma BC; Sharma P; Agrawal A; Sarin SK
Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
Irimia R; Trifan A
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
[TBL] [Abstract][Full Text] [Related]
16. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial.
Morgan MY; Hawley KE
Hepatology; 1987; 7(6):1278-84. PubMed ID: 3315932
[TBL] [Abstract][Full Text] [Related]
17. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
Prasad S; Dhiman RK; Duseja A; Chawla YK; Sharma A; Agarwal R
Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
[TBL] [Abstract][Full Text] [Related]
18. [Acidifying therapy in the combined treatment of patients with liver cirrhosis].
Chervak IM
Lik Sprava; 1998; (2):82-5. PubMed ID: 9670665
[TBL] [Abstract][Full Text] [Related]
19. Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
Heredia D; Terés J; Orteu N; Rodés J
J Hepatol; 1988 Aug; 7(1):106-10. PubMed ID: 3053887
[TBL] [Abstract][Full Text] [Related]
20. Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding.
Higuera-de-la-Tijera F; Servín-Caamaño AI; Salas-Gordillo F; Pérez-Hernández JL; Abdo-Francis JM; Camacho-Aguilera J; Alla SN; Jiménez-Ponce F
Can J Gastroenterol Hepatol; 2018; 2018():3015891. PubMed ID: 30079329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
